跳至主要内容
临床试验/CTRI/2025/08/092702
CTRI/2025/08/092702已完成不适用

Clinical Study to Evaluate the Efficacy of Narie Thyroid Care in the management of Hypothyroidism

Zeroharm Sciences Private Limited1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年8月19日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
nvestigation 1. Blood Routine Examination (Blood R/E)

研究概览

简要总结

This clinical study evaluates the efficacy and safety of Zeroharm Narie Thyroid Care, an Ayurvedic formulation, in patients with hypothyroidism. Participants diagnosed with hypothyroidism will receive Narie Thyroid Care tablets daily for 3 months. Two follow-up visits will be conducted at 1-month intervals to assess progress and monitor safety.

Laboratory tests, including TSH, T3, and T4, will be performed before and after treatment. Clinical symptoms such as fatigue, weight gain, cold intolerance, and mood changes will be tracked.

Patients will be monitored for any adverse events or side effects throughout the study. The primary endpoint is improvement in thyroid hormone levels and symptom relief.

Secondary endpoints include safety, compliance, and quality-of-life measures. Data will be statistically analyzed to evaluate the therapeutic effectiveness.

The study aims to validate Narie Thyroid Care as a natural support for hypothyroidism management.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
Female

入选标准

  • Diagnosed cases of hypothyroidism based on serum TSH,T3 and T4 levels Subjects not suffering from any significant illness (medical / surgical) Subjects willing to follow the procedures as per the study protocol and voluntarily sign an informed consent form.

排除标准

  • Pregnant and lactating mother.
  • suffering with Chronic illness.

结局指标

主要结局

nvestigation 1. Blood Routine Examination (Blood R/E)

时间窗: 12 weeks

2. Thyroid Profile:

时间窗: 12 weeks

Thyroid-Stimulating Hormone (TSH)

时间窗: 12 weeks

Total T4 (Thyroxine)

时间窗: 12 weeks

Total T3 (Triiodothyronine)

时间窗: 12 weeks

次要结局

  • Waynes Index-Showing the scoring of signs and symptoms for the diagnosis of hypothyroidism(12 weeks)

研究者

发起方
Zeroharm Sciences Private Limited
申办方类型
Other [Neutracutical Company ]
责任方
Principal Investigator
主要研究者

Dr Dipak Kumar Goswami

Government Ayurvedic College Jalukbari Guwahati 14 Assam

研究点 (1)

Loading locations...

相似试验

Zeroharm Narie Thyroid Care Tablets A Gentle,... | 临床试验